A wireless, programmable stroboscopic eyewear device is used to clear amyloid proteins from the brain. The device employs passive, non-invasive stroboscopic lens technology to combat buildup of amyloid proteins in the brain by improving gamma oscillations in the brain. The wearable device delivers non-invasive stroboscopic stimulation in the 20-60 Hz range. Treatment sessions are for an average of twenty minutes a day, seven days a week through passive use. The wearable device transmits data to a smartphone based mobile application, as a means to encourage an effective treatment protocol as determined and monitored by the user's physicians and caregivers. The stroboscopic effect is created through the synchronized opening and closing of Liquid Crystal Display (LCD) lenses which electronically switch from clear to opaque, utilizing noninvasive ambient light to create the strobe effect, as opposed to invasive flashing lights.
